The Fund Grade · free · no account needed
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Fidelity Select Technology Portfolio
#83 of 500 graded active funds · blend · large segment peer group
The point · specialist footprint
FSPTX puts more of its book behind proven specialists than 87% of graded funds.
Bottom 20%
Bottom 40%
Middle
Top 40%
● Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
FSPTX vs the Honor Roll · share card ↗Conviction exposure
53.5%
of the book in specialist-converged names
Late-stage weight
6.1%
of the book in Crowded or Fading names
Active share
86.1%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
FSPTX earns an A grade and ranks 83rd out of 500 graded funds, with specialists making up 53.5% of its backing. The fund looks early on KLAC and JBL, both in the Emerging stage. Watch AVGO at 3.4% weight, where specialists are already leaving.
→ Track AVGO closely, as specialists are fading from a position that makes up 3.4% of the fund.
→ Note the early Emerging stage entries in KLAC and JBL, where the fund appears genuinely ahead of broader consensus.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.